José Van der Heyden

4.9k total citations · 1 hit paper
61 papers, 4.0k citations indexed

About

José Van der Heyden is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, José Van der Heyden has authored 61 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 27 papers in Molecular Biology and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in José Van der Heyden's work include Monoclonal and Polyclonal Antibodies Research (19 papers), Cytokine Signaling Pathways and Interactions (13 papers) and Viral Infectious Diseases and Gene Expression in Insects (10 papers). José Van der Heyden is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (19 papers), Cytokine Signaling Pathways and Interactions (13 papers) and Viral Infectious Diseases and Gene Expression in Insects (10 papers). José Van der Heyden collaborates with scholars based in Belgium, France and United States. José Van der Heyden's co-authors include Jan Tavernier, René Devos, Walter Fiers, Geert Plaetinck, Lucie Fransen, Walter Fiers, Sigrid Cornelis, T Tuypens, Yves Guisez and Annick Verhee and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

José Van der Heyden

60 papers receiving 3.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF

1991 511 citations Jan Tavernier, René Devos et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
José Van der Heyden Belgium	32	2.1k	1.3k	872	665	559	61	4.0k
Jarema Kochan United States	33	1.7k 0.8×	1.3k 1.0×	250 0.3×	734 1.1×	885 1.6×	68	4.2k
Craig Gerard United States	20	2.3k 1.1×	1.7k 1.3×	1.0k 1.2×	574 0.9×	275 0.5×	26	4.2k
DW Golde United States	45	2.4k 1.1×	1.6k 1.3×	1.1k 1.3×	557 0.8×	230 0.4×	126	6.2k
Giacomo Paonessa Italy	29	722 0.3×	1.6k 1.3×	794 0.9×	202 0.3×	271 0.5×	54	3.6k
Emily Rinderknecht Germany	18	1.4k 0.7×	1.8k 1.5×	433 0.5×	277 0.4×	367 0.7×	28	4.2k
Susan R. Schwab United States	28	2.9k 1.4×	3.4k 2.7×	870 1.0×	655 1.0×	170 0.3×	37	5.8k
Hidechika Okada Japan	32	1.7k 0.8×	987 0.8×	407 0.5×	499 0.8×	224 0.4×	142	3.7k
Carlo Pucillo Italy	37	2.6k 1.3×	1.2k 0.9×	493 0.6×	800 1.2×	218 0.4×	112	4.4k
Richard J. Cornall United Kingdom	34	2.9k 1.4×	1.9k 1.5×	724 0.8×	280 0.4×	344 0.6×	83	5.8k
Vincent Brichard Belgium	37	4.8k 2.3×	2.4k 1.9×	2.6k 2.9×	208 0.3×	504 0.9×	73	5.9k

Countries citing papers authored by José Van der Heyden

Since Specialization

Citations

This map shows the geographic impact of José Van der Heyden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Van der Heyden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Van der Heyden more than expected).

Fields of papers citing papers by José Van der Heyden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Van der Heyden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Van der Heyden. The network helps show where José Van der Heyden may publish in the future.

Co-authorship network of co-authors of José Van der Heyden

This figure shows the co-authorship network connecting the top 25 collaborators of José Van der Heyden. A scholar is included among the top collaborators of José Van der Heyden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Van der Heyden. José Van der Heyden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krasniqi, Ahmet, Matthias D’Huyvetter, Catarina Xavier, et al.. (2017). Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma. Molecular Cancer Therapeutics. 16(12). 2828–2839. 55 indexed citations

Cauwels, Anje, Sandra Van Lint, Franciane Paul, et al.. (2017). Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments. Cancer Research. 78(2). 463–474. 75 indexed citations

Wauman, Joris, Laura Icardi, José Van der Heyden, et al.. (2017). TYK2-induced phosphorylation of Y640 suppresses STAT3 transcriptional activity. Scientific Reports. 7(1). 15919–15919. 16 indexed citations

Garcin, Geneviève, Franciane Paul, Yann Bordat, et al.. (2014). High efficiency cell-specific targeting of cytokine activity. Nature Communications. 5(1). 3016–3016. 65 indexed citations

Lavens, Delphine, Frank Peelman, José Van der Heyden, et al.. (2009). Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis. Nucleic Acids Research. 38(6). 1902–1912. 45 indexed citations

Marijanovic, Zrinka, Josiane Ragimbeau, José Van der Heyden, Gilles Uzé, & Sandra Pellegrini. (2007). Comparable potency of IFNα2 and IFNβ on immediate JAK/STAT activation but differential down-regulation of IFNAR2. Biochemical Journal. 407(1). 141–151. 66 indexed citations

Jaitin, Diego Adhemar, Laila C. Roisman, Martynas Gavutis, et al.. (2006). Inquiring into the Differential Action of Interferons (IFNs): an IFN-α2 Mutant with Enhanced Affinity to IFNAR1 Is Functionally Similar to IFN-β. Molecular and Cellular Biology. 26(5). 1888–1897. 193 indexed citations

Zabeau, Lennart, et al.. (2003). Functional Analysis of Leptin Receptor Activation Using a Janus Kinase/Signal Transducer and Activator of Transcription Complementation Assay. Molecular Endocrinology. 18(1). 150–161. 86 indexed citations

Zabeau, Lennart, José Van der Heyden, D. Broekaert, et al.. (2001). Neutralizing monoclonal antibodies can potentiate IL-5 signaling. European Journal of Immunology. 31(4). 1087–1097. 14 indexed citations

10.

Eyckerman, Sven, Annick Verhee, José Van der Heyden, et al.. (2001). Design and application of a cytokine-receptor-based interaction trap. Nature Cell Biology. 3(12). 1114–1119. 160 indexed citations

11.

Campfield, L. Arthur, Françoise J. Smith, Geert Plaetinck, et al.. (1998). Efficient Secretion of Biologically Active Recombinant OB Protein (Leptin) inEscherichia coli,Purification from the Periplasm and Characterization. Protein Expression and Purification. 12(2). 249–258. 28 indexed citations

12.

Verploegen, Sandra, Geert Plaetinck, René Devos, José Van der Heyden, & Yves Guisez. (1997). A human leptin mutant induces weight gain in normal mice. FEBS Letters. 405(2). 237–240. 63 indexed citations

13.

Tavernier, Jan, et al.. (1995). Structure/Function Analysis of Human Interleukin 5 and its Receptor. Birkhäuser Basel eBooks. 46. 23–34. 4 indexed citations

14.

Devos, René, Yves Guisez, Geert Plaetinck, et al.. (1994). Covalent modification of the interleukin‐5 receptor by isothiazolones leads to inhibition of the binding of interleukin‐5. European Journal of Biochemistry. 225(2). 635–640. 39 indexed citations

15.

Oefner, Christian, Ernst‐Jürgen Schlaeger, M. Zulauf, et al.. (1993). Expression, purification and crystallization of fully active, glycosylated human interleukin‐5. FEBS Letters. 331(1-2). 49–52. 8 indexed citations

16.

Tavernier, Jan, René Devos, José Van der Heyden, et al.. (1989). Expression of Human and Murine Interleukin-5 in Eukaryotic Systems. DNA. 8(7). 491–501. 45 indexed citations

17.

Heyden, José Van der, Lucie Fransen, & Walter Fiers. (1986). Treatment of Murine Interferon-α/β-Sensitive and -Resistant Friend Leukemia Cells with Tumor Necrosis Factor in Combination with Murine Interferon-α/β or -γ. Journal of Interferon Research. 6(6). 633–638. 4 indexed citations

18.

Fransen, Lucie, et al.. (1986). Recombinant tumor necrosis factor: its effect and its synergism with interferon-γ on a variety of normal and transformed human cell lines. European Journal of Cancer and Clinical Oncology. 22(4). 419–426. 237 indexed citations

19.

Devos, René, et al.. (1984). Purification of Recombinant Glycosylated Human Gamma Interferon Expressed in Transformed Chinese Hamster Ovary Cells. Journal of Interferon Research. 4(4). 461–468. 28 indexed citations

20.

Devos, René, et al.. (1983). Expression and characterization of the product of a human immune interferon cDNA gene in Chinese hamster ovary cells.. Proceedings of the National Academy of Sciences. 80(15). 4654–4658. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact